A prospective randomized controlled blinded study of three bronchodilators in infants with respiratory syncytial virus bronchiolitis on mechanical ventilation

Pediatric Critical Care Medicine

Volumn 9, Issue 6, 2008, Pages 598-604

  Levin, Daniel L ^f   Garg, Abhinav ^a,f   Hall, Leila J ^a,b,f   Slogic, Scott ^f   Jarvis, J Dean ^e,f   Leiter, James C ^c,d,f,g  

^a Primary Care Pediatrics Physician

^b North Shore Pediatrics PC   (United States)

^c Potomac Pediatric Practice   (United States)

^d Department of Physiology and Medicine ^*

^e DARTMOUTH MEDICAL SCHOOL   (United States)

^f CHILDREN S HOSPITAL AT DARTMOUTH   (United States)

^g DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEVALBUTEROL; NORADRENALIN; PLACEBO; SALBUTAMOL; SODIUM CHLORIDE; ADRENALIN; BRONCHODILATING AGENT;

ACUTE RESPIRATORY FAILURE; AIRWAY RESISTANCE; ARTICLE; ARTIFICIAL VENTILATION; BREATHING RATE; BRONCHODILATATION; CLINICAL ARTICLE; CLINICAL INDICATOR; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; END TIDAL CARBON DIOXIDE TENSION; ENDOBRONCHIAL INTUBATION; FEMALE; HEART RATE; HUMAN; INFANT; INTENSIVE CARE; MALE; OXYGEN SATURATION; PEAK INSPIRATORY FLOW; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SIDE EFFECT; SINGLE BLIND PROCEDURE; TERTIARY HEALTH CARE; TREATMENT RESPONSE; UNITED STATES; VIRAL BRONCHIOLITIS; DRUG EFFECT; PATHOPHYSIOLOGY; VIRUS INFECTION;

AIRWAY RESISTANCE; ALBUTEROL; BRONCHIOLITIS, VIRAL; BRONCHODILATOR AGENTS; EPINEPHRINE; FEMALE; HUMANS; INFANT; MALE; PROSPECTIVE STUDIES; RESPIRATION, ARTIFICIAL; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS;

EID: 60549107699     PISSN: 15297535     EISSN: None     Source Type: Journal    
DOI: 10.1097/PCC.0b013e31818c82b4     Document Type: Article

References (57)

1. Christakis DA, Cowan CA, Garrison MM, et al: Variation in inpatient testing and management of bronchiolitis. Pediatrics 2005; 115:878-884
2. Brooks A, McBride JT, McConnochie MD, et al: Predicting deterioration in previously healthy infants hospitalized with respiratory syncytial virus infection. Pediatrics 1999; 104:463-467
3. Klassen TP: Recent advances in the treatment of bronchiolitis and laryngitis. Pediatr Clin N Am 1997; 44:249-261
4. Guerguerian AM, Gauthier M, Lebel MH, et al: Ribaviron in ventilated respiratory syncy-tial viral bronchiolitis. A randomized, placebo-controlled trial. Am J Respir Crit Care Med 1999; 160:829-834
5. Tal A, Yishay EB, Godfrey S: Use of whole body infant plethysmograph to study the response of wheezy infants to treatment. Prog Resp Res 1981; 17:299-300
6. Soto ME, Sly PD, Uren E, et al: Bronchodi-lator response during acute viral bronchioli-tis in infancy. Pediatr Pulmonol 1985; 1:85-89
7. Schuh S, Canny G, Reisman JJ, et al: Nebulized albuterol in acute bronchiolitis. J Pediatr 1990; 117:633-637
8. Klassen TR, Rowe PC, Sutcliffe T, et al: Randomized trial of salbutamol in acute bron-chiolitis. J Pediatr 1991; 118:807-811
9. Alario AJ, Lewander WJ, Dennehy P, et al: The efficacy of nebulized metaproterenol in wheezing infants and young children. AJDC 1992; 146:412-418
10. Phelan PD, Williams HE: Sympathomimetic drugs in acute viral bronchiolitis: Their effect on pulmonary resistance. Pediatrics 1969; 44:493-497
11. Rutter N, Milner AD, Hiller EJ: Effect of bronchodilators on respiratory resistance in infants and young children with bronchioli-tis and wheezy bronchitis. Arch Dis Childhood 1975; 50:719-722
12. Stokes GM, Milner AD, Hodges IG, et al: Nebulised therapy in acute severe bronchi-olitis in infancy. Arch Dis Childhood 1983; 58:279-283
13. O'Callaghan C, Milner AD, Swarbrick A: Paradoxical deterioration in lung function after nebulized salbutamol in wheezy infants. Lancet 1986; 20:1424-1425
14. Hughes D, Lesouef PN, Landau L: Effect of salbutamol on respiratory mechanics in bronchiolitis. Pediatr Res 1987; 22:83-86
15. Prendiville SG, Green S, Silverman M: Par- adoxical response to nebulised salbutamol in wheezy infants, assessed by partial expi-ratory flow-volume curves. Thorax 1987; 42:86-91
16. Seidenberg J, Mir Y, von der Hart H: Hy-poxaemia after nebulised salbutamol in wheezy infants: the importance of aerosol acidity. Arch Dis Childhood 1991; 66: 672-675
17. Sly PD, Lanteri CJ, Raven JM: Do wheezy infants recovering from bronchiolitis respond to inhaled salbutamol? Pediatr Pulmo-nol 1991; 10:36-39
18. Ho L, Collis G, Landau LI, et al: Effect of salbutamol on oxygen saturation in bronchi-olitis. Arch Dis Childhood 1991; 66: 1061-1064
19. Goodman T, Chambers TL: Bronchodilators for bronchiolitis? Lancet 1993; 341:1380
20. Gadomski A, Aref G, Badr O, et al: Oral versus nebulized albuterol in the management of bronchiolitis in Egypt. J Pediatr 1994; 124: 131-138
21. Goh A, Chay OM, Foo AL, et al: Efficacy of bronchodilators in the treatment of bronchiolitis. Singapore Med J 1997; 38:326-328
22. Holland WW, Colley JR, Barraclough MA: Measurement of respiratory effort and assessment of a method of treating lower-respiratory-tract infections in small children. Lancet 1960:1166-1169
23. Lowell DI, Lister G, Von Koss H, et al: Wheezing in infants: The response to epinephrine. Pediatrics 1987; 79:939-945
24. Sanchez I, De Koster J, Powell R, et al: Effect of racemic epinephrine and salbutamol on clinical score and pulmonary mechanics in infants with bronchiolitis. J Pediatr 1993; 122:145-151
25. Kristjánsson S, Lødrup Carlsen KC, Wenner-gren G, et al: Nebulised racemic adrenaline in the treatment of acute bronchiolitis in infants and toddlers. Arch Dis Childhood 1993; 69:650-654
26. Reijonen T, Korppi M, Pitkahangas S, et al: The clinical efficacy of nebulized racemic epinephrine and albuterol in acute bronchiolitis. Arch Pediatr Adolesc Med 1995; 149: 686-692
27. Menon K, Sutcliffe T, Klassen T: A randomized trial comparing the efficacy of epineph-rine with salbutamol in the treatment of acute bronchiolitis. J Pediatr 1995; 126: 1004-1007
28. Barr F, Patel N, Newth C: The pharmacologic mechanism by which inhaled epinephrine reduces airway obstruction in respiratory syncytial virus-associated bronchioloitis. J Pediatr 2000; 136:699-700
29. Motoyama E, Lister G, Mallory G, et al: Evidence of bronchial hyperreactivity in infants with severe bronchiolitis. Ped Res 1982; 16: 358A
30. Mallory G, Motoyama E, Koumbourlis AC, et al: Bronchial reactivity in infants in acute respiratory failure with viral bronchiolitis. Pediatr Pulmonol 1989; 6:253-259
31. Hammer J, Numa A, Newth C: Albuterol responsiveness in infants with respiratory failure caused by respiratory syncytial virus infection. J Pediatr 1995; 127:485-490
32. Derish M, Hodge G, Dunn C, Ariagno R: Aerosolized albuterol improves airway reactivity in infants with acute respiratory failure from respiratory syncytial virus. Pediatr Pul-monol 1998; 26:12-20
33. Lenney W, Milner AD: At what age do bron-chodilator drugs work? Arch Dis Childhood 1978; 53:532-535
34. Tepper RS: Airway reactivity in infants: A positive response to methacholine and metaproterenol. J Appl Physiol 1987; 62:1155-1159
35. Levy B, Graber M: Respiratory syncytial virus infection in infants and young children. J Fam Practice 1997; 45:473-481
36. Hoshiko K, Morley J: Exacerbation of airway hyperreactivity by (-/ ) salbutamol in sensitized guinea pig. Jpn J Pharmacol 1993; 63:159-163
37. Johansson F, Rydberg I, Aberg G, et al: Effects of albuterol enantiomers on in vitro bronchial reactivity. Clin Rev Allergy Immu-nol 1996; 14:57-64
38. Penn RB, Frielle T, McCullough JR, et al: Comparision of R-, S-, and RS-albuterol interaction with human beta 1- and beta 2-ad-renergic receptors. Clin Rev Allergy Immunol 1996; 14:37-45
39. Morley J: Anomalous effects of albuterol and other sympathomimetics in the guinea pig. Clin Rev Allergy Immunol 1996; 14:65-89
40. Yamaguchi H, McCullough JR: S-albuterol exacerbates calcium responses to carbachol in airway smooth muscle cells. Clin Rev Allergy Immunol 1996; 14:47-55
41. Walle T, Eaton EA, Walle UK, et al: Stereo-selective metabolism of RS-albuterol in humans. Clinl Rev Allergy Immunol 1996; 14: 101-113
42. Bakale RP, Wald SA, Butler HT, et al: Albu-terol: A pharmaceutical chemistry review of R-, S-, and RS-albuterol. Clin Rev Allergy Immunol 1996; 14:7-35
43. Nelson HS, Bensch G, Pleskow WW, et al: Improved bronchodilation with levalbuterol compared with racemic albuterol in patients with asthma. J Allergy Clin Immunol 1998; 102:943-951
44. Mitra S, Ugur M, Ugur O, et al: (S)-Albuterol increases intracellular free calcium by mus-carinic receptor activation and a phospho-lipase c-dependant mechanism in airway smooth muscle. Mol Pharmacol 1998; 50: 347-354
45. Boulton DW, Fawcett JP: Enantioselective disposition of salbutamol in man following oral and intravenous administration. Br J Clin Pharmacol 1996; 41:35-40
46. Albuterol, Levalbuterol, Racemic Epineph-rine: Clinical Pharmacology 2008, Gold Standard Version 8.06.
47. Kellner JD, Ohlsson A, Gadomski AM, et al: Efficacy of bronchodilator therapy in bron-chiolitis. A meta-analysis. Arch Pediatr Ado-lesc Med 1996; 150:1166-1172
48. Klassen TP: Determining the benefit of bron-chodilators in bronchiolitis. When is there enough benefit to warrant adoption into clinical practice? Arch Pediatr Adolesc Med 1996; 150:1120-1121
49. Dawson K, Kennedy D, Asher I, et al: The management of acute bronchiolitis. J Paediatr Child Health 1993; 29:335-337
50. Wang E, Law B, Boucher F, et al: Pediatric investigators collaborative network on infections in Canada (PICNIC) study of admission and management variation in patients hospitalized with respiratory syncytial viral lower respiratory tract infection. J Pediatr 1996; 129:390-395
51. Kimpen J, Schaad U: Treatment of respiratory syncytial virus bronchiolitis: 1995 poll of members of the European Society for Paediatric Infectious Diseases. Pediatr Infect Dis J 1997; 16:479-481
52. Kornecki A, Shemie S: Bronchodilators and RSV-induced respiratory failure: ago- nizing about-2 agonists. Pediatr Pulmonol 1998; 26:4-5
53. Anas NG: Respiratory failure. In: Essentials of Pediatric Intensive Care. Levin DL, Morris FC (Eds), 2nd Ed, Chapter 9. Churchill Livingston, Quality Medical Publisher NY, 1997, pp 69-82.
54. Takamoto CK, Hodding JH, Kraus DM: Pe- diatric Dosage Handbook, 13th edition; Lexi-Comp, Hudson OH.
55. Seimans-Elma AB: Electromedical Division. Servo Ultra Nebulizer 345 Operating Manuel, 5th edition. Philadelphia, PA: WB Saunders, 2005
56. Kemming GI, Kreyling W, Hablar O, et al: Aerosal production and aerosol droplet size distribution during mechanical ventilation (IPPV) with a new ultrasonic nebulizer. Eur J Med Res 1996; 1:321-327
57. Gay P, Rodarte JR, Tayyab M, et al: Evaluation of bronchodilator responsiveness in mechanically ventilated patients. Am Rev Respir 1987; 136:880-885